Health Care: Drugs

Immunomedics Inc (IMMU: NASDAQ)

$3.24 n/a | n/a%
09/18/14 - 04:00 PM ET
Company Income Statement
Jun 2014 Jun 2013 Jun 2012 Jun 2011
Sales 9.04M 4.96M 32.73M 14.71M
Cost of Sales 37.31M 28.70M 427.04K 419.35K
Gross Operating Profit -28.27M -23.74M 32.31M 14.29M
Selling, General, and Administrative Expenses 9.41M 6.98M 6.61M 7.94M
Research & Development 0.00 0.00 24.82M 25.37M
Operating Income before D & A (EBITDA) -37.69M -30.72M 874.17K -19.02M
Depreciation & Amortization -2.10M 859.37K 1.50M 1.36M
Interest Income 55.92K 10.56K 18.76K 519.01K
Other Income - Net 938.00 19.34M 13.23K 3.37M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -35.52M -12.23M -590.62K -16.49M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -35.52M -12.23M -590.62K -16.49M
Income Taxes 7.79K 44.07K 209.78K 109.88K
Minority Interest -105.35K -104.76K -113.57K -173.99K
Net Income From Continuing Operations -35.53M -12.27M 696.38K -15.24M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -35.53M -12.27M 696.38K -15.24M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -35.43M -12.17M 809.95K -15.07M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-35.53M -12.27M 696.38K -15.24M
Preferred Dividends
Net Income Available To Common -35.53M -12.27M 696.38K -15.24M
Basic EPS from Continuing Ops. -0.42 -0.16 0.01 -0.20
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.42 -0.16 0.01 -0.20
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.42 -0.16 0.01 -0.20
Basic Normalized Net Income/Share -0.42 -0.16 0.01 -0.20
EPS fr Continuing Ops. -0.42 -0.16 0.01 -0.20
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.42 -0.16 0.01 -0.20
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.42 -0.16 0.01 -0.20
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.42 -0.16 0.01 -0.20
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with IMMU

Latest IMMU Headlines from TheStreet

More Financial News for IMMU

Press Releases for IMMU

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter